Precision BioSciences, Inc. (DTIL)
7.78
-0.62
(-7.38%)
USD |
NASDAQ |
Aug 28, 16:00
7.80
+0.02
(+0.26%)
After-Hours: 20:00
Precision BioSciences Total Assets (Quarterly) : 125.92M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 125.92M |
| March 31, 2026 | 143.89M |
| December 31, 2025 | 154.42M |
| September 30, 2025 | 93.51M |
| June 30, 2025 | 108.93M |
| March 31, 2025 | 124.41M |
| December 31, 2024 | 136.39M |
| September 30, 2024 | 153.26M |
| June 30, 2024 | 165.80M |
| March 31, 2024 | 184.74M |
| December 31, 2023 | 159.78M |
| September 30, 2023 | 164.34M |
| June 30, 2023 | 181.70M |
| March 31, 2023 | 204.50M |
| December 31, 2022 | 238.17M |
| September 30, 2022 | 271.73M |
| June 30, 2022 | 297.16M |
| March 31, 2022 | 181.35M |
| Date | Value |
|---|---|
| December 31, 2021 | 211.50M |
| September 30, 2021 | 227.20M |
| June 30, 2021 | 230.11M |
| March 31, 2021 | 262.32M |
| December 31, 2020 | 150.16M |
| September 30, 2020 | 168.69M |
| June 30, 2020 | 184.19M |
| March 31, 2020 | 214.20M |
| December 31, 2019 | 235.23M |
| September 30, 2019 | 260.30M |
| June 30, 2019 | 271.92M |
| March 31, 2019 | 166.80M |
| December 31, 2018 | 138.60M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 72.68M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 95.64B |
| 4D Molecular Therapeutics, Inc. | 492.62M |
| Agenus, Inc. | 172.69M |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 80.63M |
| Shareholders Equity (Quarterly) | 45.29M |
| Debt to Equity Ratio | 0.6204 |
| Current Ratio | 12.82 |
| Net Debt Paydown Yield | 0.16% |